<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pseudo-<z:e sem="disease" ids="C0030779" disease_type="Disease or Syndrome" abbrv="">Pelger-HuÃ«t anomaly</z:e> (PPHA) has been documented in association with transplant medications and other drugs </plain></SENT>
<SENT sid="1" pm="."><plain>This iatrogenic neutrophilic <z:mpath ids='MPATH_589'>dysplasia</z:mpath> is reversible with cessation or adjustment of medications but is frequently confused with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) based on the conventional concept that PPHA is a marker for <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the clinicopathologic features in iatrogenic PPHA and compared them with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-related PPHA </plain></SENT>
<SENT sid="3" pm="."><plain>The 13 cases studied included 5 bone marrow/stem cell transplantations, 3 solid organ transplantations, 1 <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo>, 3 <z:hpo ids='HP_0005550'>chronic lymphocytic leukemias</z:hpo>, and 1 <z:hpo ids='HP_0003002'>breast carcinoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>For 12 cases, there was follow-up evaluation, and <z:hpo ids='HP_0000001'>all</z:hpo> demonstrated at least transient normalization of neutrophilic segmentation </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 9 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> demonstrated at least 2 of the following pathologic abnormalities on bone marrow biopsy: hypercellularity (8/9), morphologic <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (8/9), clonal cytogenetic abnormality (7/9), and increased blasts (3/9), whereas these abnormalities were typically absent in iatrogenic PPHA </plain></SENT>
<SENT sid="6" pm="."><plain>Iatrogenic PPHA displayed a higher proportion of circulating PPHA cells than in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (mean, 47.4%; SD, 31.6% vs mean, 12.3%; SD, 9.8; P &lt; .01) </plain></SENT>
<SENT sid="7" pm="."><plain>A diagnostic algorithm is proposed in which isolated PPHA is indicative of transient or benign PPHA unless proven otherwise </plain></SENT>
</text></document>